Sugentech Financials
| 253840 Stock | KRW 5,170 30.00 0.58% |
Sugentech |
Understanding current and past Sugentech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sugentech's financial statements are interrelated, with each one affecting the others. For example, an increase in Sugentech's assets may result in an increase in income on the income statement.
Please note, the presentation of Sugentech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sugentech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sugentech's management manipulating its earnings.
Sugentech Stock Summary
Sugentech competes with Ray Co, Access Bio, DRGEM, DHP Korea, and Sugentech. Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. Sugentech Inc. was founded in 2011 and is headquartered in Daejeon, South Korea. Sugentech is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7253840003 |
| Business Address | 187, Techno 2-ro, |
| Sector | Healthcare |
| Industry | Health Care Equipment & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | sugentech.com |
| Phone | 82 4 2364 5001 |
| Currency | KRW - South Korean Won |
You should never invest in Sugentech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Sugentech Stock, because this is throwing your money away. Analyzing the key information contained in Sugentech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Sugentech Key Financial Ratios
Sugentech's financial ratios allow both analysts and investors to convert raw data from Sugentech's financial statements into concise, actionable information that can be used to evaluate the performance of Sugentech over time and compare it to other companies across industries.| Return On Equity | 50.19 | |||
| Return On Asset | 0.31 | |||
| Number Of Employees | 96 | |||
| Beta | -4.31 | |||
| Z Score | 90.0 |
Sugentech Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sugentech's current stock value. Our valuation model uses many indicators to compare Sugentech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sugentech competition to find correlations between indicators driving Sugentech's intrinsic value. More Info.Sugentech is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers reporting about 0.01 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sugentech is roughly 162.84 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sugentech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sugentech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sugentech Systematic Risk
Sugentech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sugentech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Sugentech correlated with the market. If Beta is less than 0 Sugentech generally moves in the opposite direction as compared to the market. If Sugentech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sugentech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sugentech is generally in the same direction as the market. If Beta > 1 Sugentech moves generally in the same direction as, but more than the movement of the benchmark.
Sugentech December 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sugentech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sugentech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sugentech based on widely used predictive technical indicators. In general, we focus on analyzing Sugentech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sugentech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 17.18 | |||
| Value At Risk | (5.19) | |||
| Potential Upside | 5.14 |
Complementary Tools for Sugentech Stock analysis
When running Sugentech's price analysis, check to measure Sugentech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sugentech is operating at the current time. Most of Sugentech's value examination focuses on studying past and present price action to predict the probability of Sugentech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sugentech's price. Additionally, you may evaluate how the addition of Sugentech to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |